Skip to Content

Medpace Holdings, Inc.

Securities Class Action

  • Date:
  • 6/5/2026
  • Company Name:
  • Medpace Holdings, Inc.
  • Stock Symbol:
  • MEDP
  • Class Period:
  • FROM 4/22/2025 TO 2/9/2026
  • Status:
  • Filed
  • Filing Date:
  • 4/6/2026
  • Court:
  • U.S. District Court: District of Southern Ohio

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ:MEDP) in the United States District Court for the Southern District of Ohio on behalf of all persons and entities who purchased or otherwise acquired Medpace common stock between April 22, 2025 and February 9, 2026, both dates inclusive (the “Class Period”). Investors have until June 5, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit.


According to the Complaint, the Company made false and misleading statements to the market. Medpace engaged in a scheme to artificially inflate its share price. The Company’s misrepresentations became evident to the market through its poor performance throughout the class period. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Medpace, investors suffered damages.

If you purchased or otherwise acquired Medpace shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Medpace Holdings. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: